NCODA Logo

Navigate Medicare with Confidence

NCODA, in collaboration with the PAN Foundation, is excited to introduce a new Medicare Resource designed to help patients, caregivers, and healthcare professionals navigate the significant Medicare changes taking effect in 2025. This resource breaks down: The 2025...
2024 Fall Summit Resources

2024 Fall Summit Resources

Thursday, October 24th Fall Summit Session Handouts A Review of Prostate Cancer & Recent Updates in the Treatment of Metastatic Prostate Cancer Addressing Cancer Disparities and SDOH Unique Rural Populations Advances in Breast Cancer Treatment and Current Updates...
SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

– Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life – STAMFORD, Conn.,...